Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Kentucky Chandler Medical Center, Lexington, KY 40536-0293, USA.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Kentucky Chandler Medical Center, Lexington, KY 40536-0293, USA.
Gynecol Oncol. 2014 Feb;132(2):423-7. doi: 10.1016/j.ygyno.2013.12.008. Epub 2013 Dec 13.
The newest findings on literature utilization relevant to gynecologic oncology were published by Thomson Reuters during June 2013 as determinants of journal standing. Our objective was to assess the different metrics reported for relative impact and cost for journals relevant to gynecologic oncology.
55 journals were evaluated for Impact Factor (IF), 5 Year IF, Immediacy Index, Cited Half Life, Eigenfactor (EF) Score, Article Influence (AI) scores and subscription costs obtained from publisher information.
CA-A Cancer Journal for Clinicians had the highest IF (101.78) & AI (24.502). The top EF cancer-specific journals were the Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research and Oncogene. Rankings for Gynecologic Oncology (409 articles, 18,243 citations) were IF = 3.929, 43/55, EF = 0.038, 28/55, and AI = 1.099, 44/55, all higher than the previous year. The IF improved from the 5 year IF in 31 journals, including Gynecologic Oncology, 29/31. Subscription costs for Gynecologic Oncology compared favorably to other journals.
The high utilization of review information in CA-A Cancer Journal for Clinicians and Nature Review Cancer illustrated by the IF coupled with a relatively low number of articles and short cited half life indicates that they serve as a leading source of quoted cancer statistics (CA-A Cancer Journal for Clinicians). Rankings for Gynecologic Oncology and the International Journal of Gynecologic Cancer have improved. Regardless of specialty size, the Impact Factor for Gynecologic Oncology is respectably strong. The decreased IF in 44% of the journals may reflect the international economy's effect on cancer research.
汤森路透于 2013 年 6 月公布了与妇科肿瘤学相关的文献利用最新发现，作为期刊地位的决定因素。我们的目的是评估与妇科肿瘤学相关的期刊报道的相对影响和成本的不同指标。
评估了 55 种期刊的影响因子（IF）、5 年 IF、即时指数、半衰期、特征因子（EF）得分、文章影响（AI）评分和出版商信息获得的订阅费用。
CA-A Cancer Journal for Clinicians 的 IF（101.78）和 AI（24.502）最高。排名最高的 EF 癌症特异性期刊是《临床肿瘤学杂志》、《癌症研究》、《临床癌症研究》和《癌基因》。妇科肿瘤学（409 篇文章，18243 次引用）的排名为 IF = 3.929、43/55、EF = 0.038、28/55、AI = 1.099、44/55，均高于前一年。31 种期刊的 IF 从 5 年 IF 中提高，包括妇科肿瘤学，29/31。与其他期刊相比，妇科肿瘤学的订阅费用具有优势。
CA-A Cancer Journal for Clinicians 和 Nature Review Cancer 中评论信息的高利用率由 IF 反映出来，同时文章数量和半衰期较短，表明它们是引用癌症统计数据的主要来源（CA-A Cancer Journal for Clinicians）。妇科肿瘤学和国际妇科肿瘤学杂志的排名有所提高。无论专业规模大小，妇科肿瘤学的影响因子都相当强劲。44%的期刊 IF 下降可能反映了国际经济对癌症研究的影响。
